
検索結果 519 件
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Shien, Tadahiko| |
| 発行日 | 2019-03 |
| 出版物タイトル | Translational Cancer Research |
| 巻 | 8巻 |
| 号 | Suppl. 2号 |
| 出版者 | AME Publishing |
| 開始ページ | S118 |
| 終了ページ | S119 |
| ISSN | 2218-676X |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 論文のバージョン | publisher |
| DOI | 10.21037/tcr.2018.11.19 |
| 関連URL | isVersionOf https://doi.org/10.21037/tcr.2018.11.19 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Shien, Tadahiko| Iwata, Hiroji| |
| キーワード | breast cancer adjuvant neoadjuvant |
| 備考 | This is a pre-copyedited, author-produced version of an article accepted for publication in Japanese Journal of Clinical Oncology following peer review. The version of record TTadahiko Shien, Hiroji Iwata, Adjuvant and neoadjuvant therapy for breast cancer, Japanese Journal of Clinical Oncology, Volume 50, Issue 3, March 2020, Pages 225–229 is available online at: https://doi.org/10.1093/jjco/hyz213.| |
| 発行日 | 2020-01-28 |
| 出版物タイトル | Japanese Journal of Clinical Oncology |
| 巻 | 50巻 |
| 号 | 3号 |
| 出版者 | Oxford University Press |
| 開始ページ | 225 |
| 終了ページ | 229 |
| ISSN | 0368-2811 |
| NCID | AA00690866 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | Copyright © 2020 Oxford University Press |
| 論文のバージョン | author |
| PubMed ID | 32147701 |
| DOI | 10.1093/jjco/hyz213 |
| Web of Science KeyUT | 000536439500001 |
| 関連URL | isVersionOf https://doi.org/10.1093/jjco/hyz213 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Iwamoto, Takayuki| Fujisawa, Tomomi| Shien, Tadahiko| Araki, Kazuhiro| Sakamaki, Kentaro| Sangai, Takafumi| Kikawa, Yuichiro| Takao, Shintaro| Nishimura, Reiki| Takahashi, Masato| Aihara, Tomohiko| Mukai, Hirofumi| aira, Naruto| |
| キーワード | Metastatic breast cancer Endocrine therapies Estrogen receptor-positive HER2-negative Resistance |
| 発行日 | 2020-05-11 |
| 出版物タイトル | Breast Cancer |
| 巻 | 27巻 |
| 号 | 5号 |
| 出版者 | Springer |
| 開始ページ | 973 |
| 終了ページ | 981 |
| ISSN | 13406868 |
| NCID | AA1103354X |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 論文のバージョン | author |
| PubMed ID | 32394413 |
| DOI | 10.1007/s12282-020-01095-y |
| Web of Science KeyUT | 000531780600002 |
| 関連URL | isVersionOf https://doi.org/10.1007/s12282-020-01095-y |
| フルテキストURL | K0006129_abstract_review.pdf K0006129_summary.pdf K0006129_fulltext.pdf |
|---|---|
| 著者 | 高橋 侑子| |
| 発行日 | 2020-03-25 |
| 資料タイプ | 学位論文 |
| 学位授与番号 | 甲第6129号 |
| 学位授与年月日 | 2020-03-25 |
| 学位・専攻分野 | 博士(医学) |
| 授与大学 | 岡山大学 |
| 言語 | 英語 |
| フルテキストURL | K0006095_abstract_review.pdf K0006095_summary.pdf K0006095_fulltext.pdf |
|---|---|
| 著者 | 西山 慶子| |
| 発行日 | 2020-03-25 |
| 資料タイプ | 学位論文 |
| 学位授与番号 | 甲第6095号 |
| 学位授与年月日 | 2020-03-25 |
| 学位・専攻分野 | 博士(医学) |
| 授与大学 | 岡山大学 |
| 言語 | 英語 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Katayama, Norihisa| Sato, Shuhei| Katsui, Kuniaki| Takemoto, Mitsuhiro| Tsuda, Toshihide| Yoshida, Atsushi| Morito, Tsuneharu| Nakagawa, Tomio| Mizutani, Akifumi| Waki, Takahiro| Niiya, Harutaka| Kanazawa, Susumu| |
| キーワード | Breast cancer Breast-conserving surgery Radiotherapy Radiation-induced BOOP syndrome Endocrine therapy |
| 発行日 | 2009-03-15 |
| 出版物タイトル | International journal of radiation oncology, biology, physics |
| 巻 | 73巻 |
| 号 | 4号 |
| 出版者 | Elsevier |
| 開始ページ | 1049 |
| 終了ページ | 1054 |
| ISSN | 0360-3016 |
| NCID | AA00680920 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 論文のバージョン | author |
| PubMed ID | 18755559 |
| DOI | 10.1016/j.ijrobp.2008.05.050 |
| Web of Science KeyUT | 000264257400014 |
| 関連URL | isVersionOf https://doi.org/10.1016/j.ijrobp.2008.05.050 |
| JaLCDOI | 10.18926/AMO/58272 |
|---|---|
| フルテキストURL | 74_2_137.pdf |
| 著者 | Isozaki, Hiroshi| Yamamoto, Yasuhisa| Sakai, Kunihiko| Sho, Tatuo| Ishihara, Kiyohiro| Murakami, Shigeki| Matsumoto, Sasau| Takama, Takehiro| |
| 抄録 | Mucinous carcinoma (MC) of the breast is a rare and special type of malignancy, with a substantial amount of extracellular mucin. We compared the clinicopathological features and the long-term survival of MC patients with those of invasive ductal carcinoma-no special type (IDC-NST) patients, and we examined prognostic factors of MC. A total of 116 patients with mucinous carcinoma and 3,258 patients with IDC-NST who underwent surgery at our hospital (1977-2008) were enrolled. The 10-year overall survival rate and breast cancer-specific survival rate (BSS) of the MC patients (88.3%, 93.7%) were both significantly higher than those of IDC-NST patients (81.6%, 85.0%) (p=0.015, p=0.005, respectively). A Cox regression analysis demonstrated that MC tended to be an independent prognostic factor (hazard ratio 0.44, p=0.098). The BSS of the MC patients with positive lymph node (LN) metastasis was significantly poorer than that of the patients without it, by univariate analysis (p=0.002). The tumor size in the MC patients with positive LN metastasis (mean 3.2 cm) was significantly larger than that in the patients without it (mean 1.9 cm) (p=0.0004). Although a Cox regression analysis revealed no independent factor, MC patients with positive LN metastasis should be treated for advanced invasive ductal breast cancer. |
| キーワード | breast cancer mucinous carcinoma clinicopathological features long-term prognosis |
| Amo Type | Original Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2020-04 |
| 巻 | 74巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 137 |
| 終了ページ | 143 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 32341588 |
| Web of Science KeyUT | 000528278500007 |
| NAID | 120006839451 |
| JaLCDOI | 10.18926/AMO/58271 |
|---|---|
| フルテキストURL | 74_2_129.pdf |
| 著者 | Fukuma, Shogo| Shinya, Takayoshi| Soh, Junichi| Fukuhara, Ryuichiro| Ogawa, Nanako| Higaki, Fumiyo| Tanaka, Takehiro| Ichihara, Eiki| Hiraki, Takao| Toyooka, Shinichi| Kanazawa, Susumu| |
| 抄録 | The aim of this study was to explore enhancement patterns of different types of primary lung cancers on 2-phase dynamic computed tomography (CT). This study included 217 primary lung cancer patients (141 adenocarcinomas [ADs], 48 squamous cell carcinomas [SCCs], 20 small cell lung carcinomas [SCLCs], and 8 others) who were examined using a 2-phase dynamic scan. Regions of interest were identified and mean enhancement values were calculated. After excluding the 20 SCLCs because these lesions had different clinical stages from the other cancer types, the mean attenuation values and subtractions between phases were compared between types of non-small cell lung carcinomas (NSCLCs) using the Kruskal–Wallis test. Late phase attenuation and attenuation of the late minus unenhanced phase (LMU) of SCCs were significantly higher than those of ADs (p<0.05). To differentiate SCC and AD in the late phase, a threshold of 80.21 Hounsfield units (HU) gave 52.9% accuracy. In LMU, a threshold of 52.16 HU gave 59.3% accuracy. Dynamic lung CT has the potential to aid in differentiating among NSCLC types. |
| キーワード | differentiation dynamic computed tomography primary lung cancer enhancement pattern |
| Amo Type | Original Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2020-04 |
| 巻 | 74巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 129 |
| 終了ページ | 135 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 32341587 |
| Web of Science KeyUT | 000528278500006 |
| NAID | 120006839450 |
| JaLCDOI | 10.18926/AMO/58268 |
|---|---|
| フルテキストURL | 74_2_109.pdf |
| 著者 | Ogawa, Chikako| Nakamura, Keiichiro| Matsuoka, Hirofumi| Matsubara, Yuko| Haraga, Junko| Masuyama, Hisashi| |
| 抄録 | This study aimed to determine whether the risk conferred by gynecologic cancer (GC) as second primary cancer (SPC) differs from that associated with GC as first primary cancer (FPC). We investigated the correlations between FPC/SPC and the characteristics and prognoses of 1,645 GC patients (701 with cervical cancer [CC], 641 with endometrial cancer [EM], and 303 with ovarian cancer [OV]). The χ2 test and the Kaplan–Meier method were used to determine whether FPC/SPC and the characteristics and prognoses of GC patients. Of the SPC patients, 26 (3.7%) had CC, 53 (8.3%) had EM, and 31 (10.2%) had OV. The most common previous cancer type in SPC of GC patients was breast cancer, which was observed in 13 patients (50.0%) with CC, 23 (43.4%) with EM, and 16 (51.6%) with OV. In all patients with CC, EM, and OV as SPC, the stage was significantly associated with recurrence. There were no significant differences in the morbidity or mortality of CC, EM, or OV patients between those with FPC and those with SPC. The risk of SPC development in GC patients varied, ranging from 3.5% (CC) to 10.3% (OV) of patients. |
| キーワード | second primary cancer gynecologic cancer prognosis |
| Amo Type | Original Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2020-04 |
| 巻 | 74巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 109 |
| 終了ページ | 114 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 32341584 |
| Web of Science KeyUT | 000528278500003 |
| NAID | 120006839447 |
| JaLCDOI | 10.18926/AMO/58266 |
|---|---|
| フルテキストURL | 74_2_95.pdf |
| 著者 | Kuba, Sayaka| Yamanouchi, Kosho| Morita, Michi| Sakimura, Chika| Inamasu, Eiko| Hatachi, Toshiko| Otsubo, Ryota| Matsumoto, Megumi| Yano, Hiroshi| Miyamoto, Junya| Sato, Shuntaro| Nakagawa, Hiroo| Kanetaka, Kengo| Takatsuki, Mitsuhisa| Nagayasu, Takeshi| Eguchi, Susumu| |
| 抄録 | We assessed the usefulness of ChemoCalc, a software package for calculating drug costs, in helping patients understand these costs. We randomly assigned, in a 1 : 1 ratio, 20 women who had undergone surgery for early breast cancer to a group that discussed adjuvant treatment with their physicians using the ChemoCalc software (ChemoCalc group) or a group that discussed adjuvant treatment without ChemoCalc (Usual Explanation group). The participants completed a five-grade evaluation questionnaire after these discussions. The primary endpoint was the intergroup comparison of the questionnaire scores regarding participants’ understanding of their treatment-associated drug costs. Median age was not significantly different between the ChemoCalc group and Usual Explanation group (57 vs. 50, respectively; p=0.27). Patients in the ChemoCalc group had a significantly higher perceived level of understanding of the drug cost than those in the Usual Explanation group (5 [4-5] vs. 2.5 [1-5], respectively; p=0.002). Scores related to the patients’ perception that understanding drug costs is an important part of breast cancer treatment were also higher in the ChemoCalc group than the Usual Explanation group (5 [2-5] vs. 3 [1-5], respectively; p=0.049). ChemoCalc was found to be useful for understanding drug costs. |
| キーワード | breast cancer drug costs ChemoCalc |
| Amo Type | Original Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2020-04 |
| 巻 | 74巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 95 |
| 終了ページ | 101 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 32341582 |
| Web of Science KeyUT | 000528278500001 |
| NAID | 120006839445 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Hirano, Yutaka| Sugimoto, Seiichiro| Yamamoto, Sumiharu| Okada, Masanori| Otani, Shinji| Ohara, Toshiaki| Yamane, Masaomi| Matsukawa, Akihiro| Oto, Takahiro| Toyooka, Shinichi| |
| キーワード | Brain dead donor Donation after cardiac death Lung transplantation Organ preservation Rejection |
| 備考 | This is a post-peer-review, pre-copyedit version of an article published in General Thoracic and Cardiovascular Surgery. The final authenticated version is available online at: http://dx.doi.org/10.1007/s11748-019-01181-9.| |
| 発行日 | 2019-07-31 |
| 出版物タイトル | General Thoracic and Cardiovascular Surgery |
| 巻 | 68巻 |
| 号 | 1号 |
| 出版者 | Springer |
| 開始ページ | 57 |
| 終了ページ | 62 |
| ISSN | 1863-6705 |
| NCID | AA12201344 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 論文のバージョン | author |
| PubMed ID | 31367969 |
| DOI | 10.1007/s11748-019-01181-9 |
| Web of Science KeyUT | 000511499200009 |
| 関連URL | isVersionOf https://doi.org/10.1007/s11748-019-01181-9 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Matsubara, Takehiro| Soh, Junichi| Morita, Mizuki| Uwabo, Takahiro| Tomida, Shuta| Fujiwara, Toshiyoshi| Kanazawa, Susumu| Toyooka, Shinichi| Hirasawa, Akira| |
| 発行日 | 2020-02-27 |
| 出版物タイトル | BioMed Research International |
| 巻 | 2020巻 |
| 出版者 | Hindawi |
| 開始ページ | 9349132 |
| ISSN | 2314-6133 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © 2020 Takehiro Matsubara et al. |
| 論文のバージョン | publisher |
| PubMed ID | 32185225 |
| DOI | 10.1155/2020/9349132 |
| Web of Science KeyUT | 000522222100002 |
| 関連URL | isVersionOf https://doi.org/10.1155/2020/9349132 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Takeda, Tatsuaki| Yamamoto, Hiromasa| Suzawa, Ken| Tomida, Shuta| Miyauchi, Shunsaku| Araki, Kota| Nakata, Kentaro| Miura, Akihiro| Namba, Kei| Shien, Kazuhiko| Soh, Junichi| Shien, Tadahiko| Kitamura, Yoshihisa| Sendo, Toshiaki| Toyooka, Shinichi| |
| キーワード | breast cancer drug resistance lung cancer neratinib YES1 |
| 発行日 | 2019-12-19 |
| 出版物タイトル | Cancer Science |
| 巻 | 111巻 |
| 号 | 3号 |
| 出版者 | Wiley |
| 開始ページ | 849 |
| 終了ページ | 856 |
| ISSN | 1347-9032 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © 2019 The Authors. |
| 論文のバージョン | publisher |
| PubMed ID | 31856375 |
| DOI | 10.1111/cas.14289 |
| Web of Science KeyUT | 000507433400001 |
| 関連URL | isVersionOf https://doi.org/10.1111/cas.14289 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Suzuki, Yoko| Taniguchi, Kohei| Hatono, Minami| Kajiwara, Yukiko| Abe, Yuko| Kawada, Kengo| Tsukioki, Takahiro| Kochi, Mariko| Nishiyama, Keiko| Iwamoto, Takayuki| Ikeda, Hirokuni| Shien, Tadahiko| Taira, Naruto| Tabata, Masahiro| Yanai, Hiroyuki| Doihara, Hiroyoshi| |
| キーワード | Radiation-induced angiosarcoma Radiotherapy Breast-conserving surgery Breast cancer Paclitaxel therapy Adjuvant therapy of angiosarcoma |
| 発行日 | 2020-01-16 |
| 出版物タイトル | Surgical Case Reports |
| 巻 | 6巻 |
| 号 | 1号 |
| 出版者 | SpringerOpen |
| 開始ページ | 25 |
| ISSN | 2198-7793 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © The Author(s). 2020 |
| 論文のバージョン | publisher |
| PubMed ID | 31950295 |
| DOI | 10.1186/s40792-020-0790-7 |
| Web of Science KeyUT | 000513920900001 |
| 関連URL | isVersionOf https://doi.org/10.1186/s40792-020-0790-7 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Yamamoto, Haruchika| Miyoshi, Kentaroh| Otani, Shinji| Kurosaki, Takeshi| Sugimoto, Seiichiro| Yamane, Masaomi| Toyooka, Shinichi| Kobayashi, Motomu| Oto, Takahiro| |
| キーワード | Inverted lung transplantation Pericardial conduit Pulmonary venous anastomosis Vessel formation |
| 発行日 | 2020-02-19 |
| 出版物タイトル | BMC Pulmonary Medicine |
| 巻 | 20巻 |
| 号 | 1号 |
| 出版者 | BMC |
| 開始ページ | 46 |
| ISSN | 1471-2466 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © The Author(s). 2020 |
| 論文のバージョン | publisher |
| PubMed ID | 32075616 |
| DOI | 10.1186/s12890-020-1075-4 |
| Web of Science KeyUT | 000517294200001 |
| 関連URL | isVersionOf https://doi.org/10.1186/s12890-020-1075-4 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Zahra, Maram Hussein| Salem, Tarek A. R.| El-Aarag, Bishoy| Yosri, Nermeen| EL-Ghlban, Samah| Zaki, Kholoud| Marei, Amel H.| Abd El-Wahed, Aida| Saeed, Aamer| Khatib, Alfi| AlAjmi, Mohamed F.| Shathili, Abdulrahman M.| Xiao, Jianbo| Khalifa, Shaden A. M.| El-Seedi, Hesham R.| |
| キーワード | Alpinia zerumbet 5,6-dehydrokawain Ehrlich ascites carcinoma anti-tumor anti-oxidant |
| 発行日 | 2019-07-08 |
| 出版物タイトル | Molecules |
| 巻 | 24巻 |
| 号 | 13号 |
| 出版者 | MDPI |
| 開始ページ | 2495 |
| ISSN | 1420-3049 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © 2019 by the authors. |
| 論文のバージョン | publisher |
| PubMed ID | 31288458 |
| DOI | 10.3390/molecules24132495 |
| Web of Science KeyUT | 000476700300149 |
| 関連URL | isVersionOf https://doi.org/10.3390/molecules24132495 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Yoshimura, Teizo| Nakamura, Kaoru| Li, Chunning| Fujisawa, Masayoshi| Shiina, Tsuyoshi| Imamura, Mayu| Li, Tiantian| Mukaida, Naofumi| Matsukawa, Akihiro| |
| キーワード | macrophages chemokines cytokines inflammation tumor microenvironment breast cancer |
| 発行日 | 2019-12-16 |
| 出版物タイトル | International Journal of Molecular Sciences |
| 巻 | 20巻 |
| 号 | 24号 |
| 出版者 | MDPI |
| ISSN | 1422-0067 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © 2019 by the authors. |
| 論文のバージョン | publisher |
| PubMed ID | 31888216 |
| DOI | 10.3390/ijms20246342 |
| Web of Science KeyUT | 000506840100235 |
| 関連URL | isVersionOf https://doi.org/10.3390/ijms20246342 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Yoshioka, Takahiro| Shien, Kazuhiko| Takeda, Tatsuaki| Takahashi, Yuta| Kurihara, Eisuke| Ogoshi, Yusuke| Namba, Kei| Torigoe, Hidejiro| Sato, Hiroki| Tomida, Shuta| Yamamoto, Hiromasa| Soh, Junichi| Fujiwara, Toshiyoshi| Toyooka, Shinichi| |
| キーワード | afatinib gastric cancer HER2 MET YES1 |
| 発行日 | 2019-06-04 |
| 出版物タイトル | Cancer Science |
| 巻 | 110巻 |
| 号 | 8号 |
| 出版者 | Wiley Open Access |
| 開始ページ | 2549 |
| 終了ページ | 2557 |
| ISSN | 1347-9032 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © 2019 The Authors. |
| 論文のバージョン | publisher |
| PubMed ID | 31162771 |
| DOI | 10.1111/cas.14089 |
| Web of Science KeyUT | 000478616800022 |
| 関連URL | isVersionOf https://doi.org/10.1111/cas.14089 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Makimoto, Go| Ohashi, Kadoaki| Taniguchi, Kohei| Soh, Junichi| Taniguchi, Akihiko| Miyahara, Nobuaki| Toyooka, Shinichi| Yoshino, Tadashi| Maeda, Yoshinobu| Kiura, Katsuyuki| |
| キーワード | IgG4-related disease Pleural effusion Adenosine deaminase Pleural biopsy Spontaneous remission |
| 発行日 | 2019 |
| 出版物タイトル | Respiratory Medicine Case Reports |
| 巻 | 28巻 |
| 出版者 | Elsevier |
| 開始ページ | 100938 |
| ISSN | 2213-0071 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © 2019 The Authors. |
| 論文のバージョン | publisher |
| PubMed ID | 31667074 |
| DOI | 10.1016/j.rmcr.2019.100938 |
| Web of Science KeyUT | 000511444900052 |
| 関連URL | isVersionOf https://doi.org/10.1016/j.rmcr.2019.100938 |
| JaLCDOI | 10.18926/AMO/57959 |
|---|---|
| フルテキストURL | 74_1_89.pdf |
| 著者 | Kada, Akiko| Fukano, Reiji| Mori, Tetsuya| Kamei, Michi| Tanaka, Fumiko| Ueyama, Junichi| Sekimizu, Masahiro| Osumi, Tomoo| Mori, Takeshi| Koga, Yuhki| Ohki, Kentaro| Fujita, Naoto| Mitsui, Tetsuo| Saito, Akiko M.| Hashimoto, Hiroya| Kobayashi, Ryoji| |
| 抄録 | No standard treatment for relapsed or refractory anaplastic large-cell lymphoma (ALCL) has been established. This study is a multicenter, open-label trial to examine the effectiveness and safety of transplantation with reduced-intensity conditioning (RIC) for patients under 20 years old with relapsed or refractory ALCL. We defined RIC as the administration of fludarabine (30 mg/m2/day) for five days plus melphalan (70 mg/m2/day) for two days and total body irradiation at 4 Gy, followed by allogeneic hematopoietic stem cell transplantation. |
| キーワード | anaplastic large-cell lymphoma relapsed/refractory fludarabine melphalan total body irradiation |
| Amo Type | Clinical Study Protocol |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2020-02 |
| 巻 | 74巻 |
| 号 | 1号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 89 |
| 終了ページ | 94 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 32099255 |
| Web of Science KeyUT | 000516606200014 |
| NAID | 120006795626 |